Discontinuation and Reinitiation of Dual-Labeled GLP-1 Receptor Agonists Among US Adults With Overweight or Obesity
Patricia J. Rodriguez(Bellevue College), Ezekiel Emanuel(University of Pennsylvania), Duy Do(Bellevue Hospital Center), Charlotte Baker(Bellevue Hospital Center), Brianna M Goodwin Cartwright(Bellevue Hospital Center), Nicholas L Stucky(Bellevue Hospital Center), Ty J. Gluckman(Providence College), Samuel Gratzl(Bellevue Hospital Center), Vincent Zhang(University of Pennsylvania)
Cited by 257
Related Papers
Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity
|JAMA Internal Medicine|2024|268
Perioperative Opioid Use and Chronic Post-Surgical Pain after Liver Transplantation: A Single Center Observational Study
|Journal of Cardiothoracic and Vascular Anesthesia|2019|25
Early MMR Vaccine Adoption During the 2025 Texas Measles Outbreak
|JAMA Network Open|2025|2
Don't Forget the Clitoris: Two Cases of Anorgasmia Due to Clitoral Dysgenesis [21I]
|Obstetrics and Gynecology|2019|0